Skye Bioscience, Inc Common Stock (SKYE) had the highest return between January 3, 2015 and January 11, 2015 by a US stock, returning 193,438.4%.
| ASSET | DATE | % RETURN |
|---|---|---|
Skye Bioscience, Inc Common Stock (SKYE) | 1/3/2015 - 1/11/2015 | 193,438.4% |
RTB Digital (RTB) | 1/3/2015 - 1/11/2015 | 200% |
Data Storage (DTST) | 1/3/2015 - 1/11/2015 | 95.31% |
TechPrecision Corporation Common stock (TPCS) | 1/3/2015 - 1/11/2015 | 84.78% |
Duos Technologies (DUOT) | 1/3/2015 - 1/11/2015 | 77.78% |
Frontline (FRO) | 1/3/2015 - 1/11/2015 | 59.51% |
Inseego (INSG) | 1/3/2015 - 1/11/2015 | 56.1% |
Fluent (FLNT) | 1/3/2015 - 1/11/2015 | 51.93% |
Ambow Education (AMBO) | 1/3/2015 - 1/11/2015 | 50% |
Halozyme Therapeutics (HALO) | 1/3/2015 - 1/11/2015 | 44.19% |
Satellos Bioscience Inc Common Stock (MSLE) | 1/3/2015 - 1/11/2015 | 42.86% |
Coherus BioSciences (CHRS) | 1/3/2015 - 1/11/2015 | 39% |
Arcturus Therapeutics (ARCT) | 1/3/2015 - 1/11/2015 | 38.85% |
Bimergen Energy (BESS) | 1/3/2015 - 1/11/2015 | 37.5% |
Eocene (EOCN) | 1/3/2015 - 1/11/2015 | 37.38% |
LightPath Technologies (LPTH) | 1/3/2015 - 1/11/2015 | 33.71% |
InnovAge (INNV) | 1/3/2015 - 1/11/2015 | 32.6% |
Agenus (AGEN) | 1/3/2015 - 1/11/2015 | 32.58% |
DarioHealth (DRIO) | 1/3/2015 - 1/11/2015 | 30.95% |
Harmony Gold Mining (HMY) | 1/3/2015 - 1/11/2015 | 30.3% |
Cardiff Oncology (CRDF) | 1/3/2015 - 1/11/2015 | 29.3% |
Scynexis (SCYX) | 1/3/2015 - 1/11/2015 | 28.66% |
Smith Micro Software (SMSI) | 1/3/2015 - 1/11/2015 | 28.57% |
Larimar Therapeutics (LRMR) | 1/3/2015 - 1/11/2015 | 28.23% |
Opus Genetics (IRD) | 1/3/2015 - 1/11/2015 | 27.78% |